Işık Batuhan ÇAKMAK, Ayşe Gülden GÜRSES, Hasan KAYA, Erol GÖKA

Brief psychotic disorder due to ephedrine

ISSN: 1018-8681
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 1984
Yayıncı: Kare Yayıncılık

___

1. Solanki P, Yadav P, Kantharia N. Ephedrine: direct, indirect or mixed acting sympathomimetic? Int J Basic Clin Pharmacol 2014; 3:431-436.

2. Vaidya VS, Mehendale HM. Ephedra: In Wexler P (editor). Encyclopedia of toxicology. Third ed. Oxford: Academic Press, 2014; 426-430.

3. Uzbay IT. Substance abuse - all aspects of addiction and addictive substances. Istanbul Tip Kitabevi, 2015. (Turkish)

4. Walton R, Manos GH. Psychosis related to ephedra-containing herbal supplement use. South Med J 2003; 96:718-720.

5. Roxanas MG, Spalding J. Ephedrine abuse psychosis. Med J Aust 1977; 2:639-640.

6. Lieberman JA, Kinon BJ, Loebel AD. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990; 16:97-110.

7. Herridge CF, O’Brook MF. Ephedrine psychosis. Br Med J 1968; 2:160.

8. Peterson E, Stoebner A, Weatherill J, Kutscher E. Case of acute psychosis from herbal supplements. S D Med 2008; 61:173-177.

9. Jacobs KM, Hirsch KA. Psychiatric complications of Ma-huang. Psychosomatics 2000; 41:58-62.

10. Miller SC. Psychiatric effects of ephedra: addiction. Am J Psychiatry 2005; 162:2198.

11. Mullen JM, Richards JR, Crawford AT. Amphetamine related psychiatric disorders. https://www.ncbi.nlm.nih.gov/books/NBK482368/. Accessed September 1, 2020.